LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
2 FTSE 100 stocks I’d buy in a stock market crash
Investing Articles
AstraZeneca shares: 3 reasons to consider buying now
Investing Articles
1 FTSE 100 stock I’d buy with £1k for 2022
Investing Articles
Should I act on the GlaxoSmithKline share price or buy AstraZeneca instead?
Investing Articles
Why AstraZeneca stock is a buy right now
Investing Articles
2022 dividend forecasts: HSBC, AstraZeneca, Glencore
Investing Articles
1 FTSE 100 stock I wouldn’t miss buying in November
Investing Articles
2 FTSE 100 dividend stocks I’d aim to never sell